Florida Hospital Cancer Institute Community Clinical Oncology Program

佛罗里达医院癌症研究所社区临床肿瘤学项目

• 批准号: 8543668
• 负责人: Lee Zehngebot
• 金额: $ 70.18万
• 依托单位: ADVENTHEALTH ORLANDO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-11 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8543668
• 关键词: Adoption; African American; Americas; Area; Award; Beds; Bone Marrow Transplantation; Breast; Cancer Center; Cancer Control; Cancer Hospital; Caribbean region; Caring; Catchment Area; Church; Clinical; Clinical Research; Clinical Treatment; Clinical Trials; Colorectal; Communities; Community Clinical Oncology Program; Community Hospitals; Community Physician; Community Trial; Controlled Study; County; Cultural Backgrounds; Data; Diagnostic; Economics; Enrollment; Ensure; Ethnic Origin; Florida; Fostering; Funding; Gastroenterologist; Geography; Gynecologic Oncology; Health; Health system; Healthcare; Healthcare Systems; Hepatobiliary; Hispanics; Hospital Referrals; Hospitals; Individual; Institutes; Institution; Intervention; Licensing; Location; Lung; Malignant Neoplasms; Medical Oncology; Medical center; Minority; Mission; Neurology; Oncologist; Operating System; Oranges; Pancreas; Participant; Patients; Pediatric Oncology; Pharmacologic Substance; Physicians; Population; Postdoctoral Fellow; Preventive; Prostate; Protestant; Protocols documentation; Quality of Care; Quality of life; Radiation Oncology; Recording of previous events; Reporting; Research; Research Personnel; Resources; Review Committee; Services; Seventh-Day Adventist; South America; Specialist; Surgeon; Surgical Oncology; Symptoms; System; Translating; Translations; Treatment Efficacy; Underinsured; Underrepresented Minority; Uninsured; United States; Urologist; Work; base; cancer prevention; cancer therapy; community organizations; control trial; decision research; experience; falls; health disparity; multidisciplinary; neuro-oncology; neurosurgery; news; outreach; prevent; programs; prospective; public health relevance; social; symposium; symptom management; therapy development; treatment trial; tumor registry

DESCRIPTION (provided by applicant): The Seventh Day Adventist Hospital System operates 37 hospitals in 10 states. In Central Florida, the Florida Hospital System has six hospital campuses (that will be participating in the FHCI-CCOP application) that bill under one license. The flagship hospital of the seven Florida Hospital System is Florida Hospital South (FH) located in Orlando, Orange County. Florida Hospital South (FH) offers a full array of services including medical oncology, radiation oncology, pediatric oncology, bone marrow transplantation, surgical oncology, neuro-oncology, and gynecologic oncology. The other five hospitals in Central Florida are located in the neighboring Oscelo and Seminole counties. A seventh hospital Florida Hospital Memorial Medical Center (MMC) is located in Volusia County. MMC is also owned by Adventist Health, but falls under a separate license. The Florida Hospital Cancer Institute (FHCI) was created to coordinate all of the cancer activities in the FH System. Dr. Lee Zehngebot has been leading the clinical activities of the FHCI for over 20 years. Dr. Zehngebot has been the architect of a successful clinical trial within the FHCI. This program has received national awards and recognition. The FHCl's Research department has a strong history of both cooperative group and pharmaceutical trials. Over the last year as we prepared for the transition to a CCOP program, FHCI enrolled CCOP credit equivalents of 56 treatment credits and 54.8 cancer control credits, with the majority of credits accrued since January 2011. In addition, FHCl's catchment area includes counties with over 40% Hispanic population and 20 % African American. While the tumor registry data only shows 11 % Hispanic and 8.5 % African American, enrollment to clinical trials shows 13% Hispanic and 10% African American. The above six hospitals in the FH System along with another MMC wish to become a CCOP. We view a CCOP award as a cornerstone to further integrate our cancer clinical trials and research programs. A CCOP award will allow FHCI to expand its clinical trials efforts in both geography and scope in the central Florida community.

描述（由申请人提供）：基督复临安息日会医院系统在10个州经营37家医院。在佛罗里达中部，佛罗里达医院系统有六个医院校区（将参与FHCI-CCOP申请），根据一个许可证收费。七家佛罗里达医院系统的旗舰医院是位于橙子县奥兰多的佛罗里达南医院（FH）。佛罗里达南医院（FH）提供全面的服务，包括内科肿瘤学、放射肿瘤学、儿科肿瘤学、骨髓移植、外科肿瘤学、神经肿瘤学和妇科肿瘤学。佛罗里达中部的其他五家医院位于邻近的奥西洛县和塞米诺尔县。第七家医院佛罗里达医院纪念医疗中心（MMC）位于沃卢西亚县。MMC也由基督复临安息日会健康，但福尔斯根据一个单独的许可证。成立了佛罗里达医院癌症研究所（FHCI），以协调FH系统中的所有癌症活动。Lee Zehngebot博士领导FHCI的临床活动已有20多年。Zehngebot博士是FHCI内成功临床试验的设计师。该计划获得了国家奖励和认可。FHCl的研究部门在合作组和药物试验方面都有着悠久的历史。在过去的一年里，当我们准备过渡到CCOP计划时，FHCI招收了相当于56个治疗学分和54.8个癌症控制学分的CCOP学分，其中大部分学分是自2011年1月以来累积的。此外，FHCl的集水区包括超过40%的西班牙裔人口和20%的非洲裔美国人的县。虽然肿瘤登记数据仅显示11%的西班牙裔和8.5%的非洲裔美国人，但临床试验的招募显示13%的西班牙裔和10%的非洲裔美国人。FH系统中的上述六家医院沿着另一家MMC希望成为CCOP。我们将CCOP奖项视为进一步整合我们的癌症临床试验和研究计划的基石。CCOP奖将使FHCI能够在佛罗里达中部社区扩大其临床试验的地理和范围。